Skip to content
Aperlena
Free alerts
Log in

Germany - Pharmaceuticals - Discount agreements under Sec. 130a(8) SGB V via open-house procedures

Original Deutschland - Arzneimittel - Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren

Open Contract notice

Key facts

Closes in
524 days
Buyer
IKK classic
Where
Germany Dresden
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products
Original language
German
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 1 month ago
Notice number
266413-2026
Watch this tender

If the deadline moves or the notice is corrected, we email you. Log in

  1. Published
  2. Today
  3. Deadline open for 685 days
  4. Awarded pending

The Aperlena Verdict

Open race

No supplier dominates: 17 different companies have won the last 18 comparable contracts from this buyer over 5 years. This is a genuinely open race.

Expected final price vs the published estimate
0%

Based on 18 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

IKK classic, a German statutory health insurance fund, announces non-exclusive rebate agreements with interested and suitable pharmaceutical companies under Sec. 130a(8) SGB V for various active substances and combinations, on uniform, non-negotiable terms. The open-house procedure runs from 01.05.2026 to 30.04.2028, with latest accession 05.03.2028. Earliest contract start is 01.05.2026 if signed documents are received by 02.04.2026. Otherwise, documents received by the 5th of a month give a contract start on the 1st of the following month; later receipt gives the 1st of the month after next. Affected products include alectinib, bisacodyl, codeine, sirolimus and others.

Description

Die IKK classic gibt hiermit bekannt, dass sie mit allen interessierten und geeigneten pharmazeutischen Unternehmen im Zeitraum vom 01.05.2026 bis zum 30.04.2028 zu verschiedenen Wirkstoffen und Wirkstoffkombinationen nicht-exklusive Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu gleichen, nicht verhandelbaren Bedingungen abschließen wird. Frühester Vertragsbeginn ist der 01.05.2026, sofern der unterschriebene Vertrag und alle nötigen Nachweise, Eigenerklärungen und Unterlagen bis zum 02.04.2026 bei der IKK classic eingehen. Danach gilt: Bei Eingang der Unterlagen bis zum 05. eines jeweiligen Monats im möglichen Beitrittszeitraum wird der jeweils 01. des Folgemonats Vertragsbeginn. Bei Eingang der Unterlagen nach dem 05. eines jeweiligen Monats im möglichen Beitrittszeitraum wird der jeweils 01. des übernächsten Folgemonats Vertragsbeginn. Ein Beitritt zur Vereinbarung ist im angegebenen Zeitraum jederzeit möglich, spätestens jedoch bis zum 05.03.2028. Weitere Angaben siehe Pkt. VI.3). Alectinib; ATC-Code: L01ED03; Amifampridin; ATC-Code: N07XX05; Bisacodyl; ATC-Code: A06AB02; Candesartan und Amlodipin; Tabletten; Packungsgröße: 90 Stück; ATC-Code: C09DB07; Clindamycin und Benzoylperoxid; ATC-Code: D10AF54 (ADV), D10AF51 (WHO); Codein; ATC-Code: R05DA04; Encorafenib; ATC-Code: L01EC03; Fenoterol und Ipratropiumbromid; ATC-Code: R03AL01; Glycopyrroniumbromid; ATC-Code: R03BB06; Hydroxycarbamid; 100 mg und 1000 mg; ATC-Code: L01XX05; Imiglucerase; ATC-Code: A16AB02; Interferon beta-1a (Rebif(R)); ATC-Code: L03AB07; Lacosamid; Infusionslösung; ATC-Code: N03AX18; Moxifloxacin; Augentropfen; ATC-Code: S01AE07; Nintedanib ; ATC-Code: L01EX09; Ribociclib; ATC-Code: L01EF02; Romiplostim; ATC-Code: B02BX04; Rufinamid; ATC-Code: N03AF03; Sirolimus; ATC-Code: L04AH01; Tafamidis; ATC-Code: N07XX08; Triptorelin; ATC-Code: L02AE04; Eculizumab; ATC-Code: L04AJ01; Caspofungin; ATC-Code: J02AX04; Folsäure; ATC-Code: B03BB01; Levomethadon; ATC-Code: N07BC05; Salmeterol und Fluticason; Inhalationspulver; ATC-Code: R03AK06

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in German.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

16 open tenders right now

Who usually wins this buyer's contracts in this sector

Company Wins Total awarded Last win
BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Dexcel Pharma GmbH; Glenmark Arzneimittel GmbH; neuraxpharm Arzneimittel GmbH; Zentiva Pharma GmbH; BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, 2 €449.2M Jul 2026
BG ALIUD STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Zentiva Pharma GmbH; 089Pharm GmbH; betapharm Arzneimittel GmbH; PUREN Pharma Gm 1 €12.5M Jan 2026
Abacus Medicine A/S 1 n/a Jan 2026
Bencard Allergie GmbH 1 n/a May 2026
EurimPharm Arzneimittel GmbH 1 n/a Jul 2026

Based on 18 awards with a linked company profile over the last 5 years.

What this buyer has paid before

Based on 17 comparable contracts this buyer awarded in this sector over the last 4 years.

Lower quartile
€1
Median award
€1
Upper quartile
€1

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Act now
    • Submission deadline: Moved 1 day EARLIER: now March 5, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.
  2. Act now
    • Submission deadline: Moved 1 day EARLIER: now March 5, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,020,608
9,792 open across Europe right now
Buyer track record on Aperlena
70 notices tracked · 29 awarded
€462,107,931 in awarded contracts

Never miss a tender like this

58 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

524 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector